Iridina Light

Benzalkonium chloride, the active ingredient in Iridina Light, is a quaternary ammonium compound presented as an ocular antiseptic solution for eye use. It provides broad‑spectrum antimicrobial activity to reduce the risk of eye infections in patients and contact lens wearers, and is used for routine pre‑operative eye preparation and post‑procedural care.

GNH USA supplies Iridina Light as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Iridina Light, a quaternary ammonium antiseptic, is employed in ocular care to control microbial contamination.

- Ocular antisepsis: Reduces microbial load on the ocular surface before surgery or invasive procedures. - Prevention of eye infections: Helps prevent bacterial and fungal infections in patients at risk. - Disinfection of contact lenses and ocular surfaces: Used to sterilize contact lenses and cleanse the eye before lens insertion.

Iridina Light may cause local ocular reactions, ranging from mild irritation to rare severe events.

Common Side Effects: - Stinging or burning sensation: Transient discomfort upon instillation. - Redness of the conjunctiva: Mild irritation that usually resolves quickly. - Tearing: Increased lacrimation as a reflex response. - Blurred vision: Temporary visual disturbance after application.

Serious or Rare Side Effects: - Allergic contact dermatitis: Persistent redness, swelling, or itching requiring medical evaluation. - Corneal epithelial damage: Ulceration or erosion of the corneal surface in susceptible individuals. - Severe ocular inflammation: Uveitis or keratitis that may need treatment. - Vision loss: Extremely rare but reported in cases of severe toxicity.

When using Iridina Light, observe the following precautions to ensure safety and effectiveness.

- Indication verification: Confirm the product is appropriate for the intended ocular procedure. - Patient history: Assess for known hypersensitivity to quaternary ammonium compounds. - Contact lens use: Remove lenses before application and wait the recommended interval before reinsertion. - Frequency of use: Follow prescriber guidance; excessive use may increase irritation risk. - Pediatric use: Exercise caution in children; only use if prescribed. - Store at ambient temperature: Keep below 25 °C, protect from moisture and direct sunlight in the original container.

Benzalkonium chloride can interact with certain ophthalmic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Preservative‑free eye drops: Simultaneous use may reduce antimicrobial effectiveness. - Topical anesthetics: May increase corneal toxicity when combined. - Antiglaucoma medications: Potential for additive ocular surface irritation.

Moderate Interactions (Monitor Closely): - Contact lens disinfecting solutions: Coordinate timing to avoid cumulative exposure. - Systemic antihistamines: May exacerbate dryness, increasing discomfort. - Other ocular antiseptics: Monitor for additive irritation.